Regulatory role of thioredoxin in homocysteine-induced monocyte chemoattractant protein-1 secretion in monocytes/macrophages

FEBS Lett. 2008 Nov 26;582(28):3893-8. doi: 10.1016/j.febslet.2008.10.030. Epub 2008 Oct 29.

Abstract

We have previously shown that homocysteine (Hcy) can induce monocyte chemoattractant protein-1 (MCP-1) secretion via reactive oxygen species (ROS) in human monocytes. Here, we show that Hcy upregulates expression of an important antioxidative protein, thioredoxin (Trx), via NADPH oxidase in human monocytes in vitro. The increase of Trx expression and activity inhibited Hcy-induced ROS production and MCP-1 secretion. Of note, 2-week hyperhomocysteinemia (HHcy) ApoE(-/-) mice showed accelerated lesion formation and parallel lower Trx expression in macrophages than ApoE(-/-) mice, suggesting that HHcy-induced sustained oxidative stress in vivo might account for impaired Trx and hence increased ROS production and MCP-1 secretion from macrophages, and subsequently accelerated atherogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apolipoproteins E / genetics
  • Atherosclerosis / metabolism
  • Atherosclerosis / pathology
  • Cells, Cultured
  • Chemokine CCL2 / metabolism*
  • Homocysteine / metabolism*
  • Homocysteine / pharmacology
  • Humans
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Mice
  • Mice, Knockout
  • Monocytes / drug effects
  • Monocytes / metabolism*
  • NADPH Oxidases / metabolism
  • Reactive Oxygen Species
  • Thioredoxins / biosynthesis
  • Thioredoxins / physiology*

Substances

  • Apolipoproteins E
  • CCL2 protein, human
  • Chemokine CCL2
  • Reactive Oxygen Species
  • Homocysteine
  • Thioredoxins
  • NADPH Oxidases